Review



rhoa g lisa activation assay kit  (Cytoskeleton Inc)


Bioz Verified Symbol Cytoskeleton Inc is a verified supplier
Bioz Manufacturer Symbol Cytoskeleton Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    Cytoskeleton Inc rhoa g lisa activation assay kit
    Aberrant AKT/mTORC2 signaling axis activation mediates TiO 2 NPs-induced F-actin disassembly and plasma membrane injury. (a, b) Western blot (a) and densitometric quantification of the p -AKT/AKT ratio (b), confirming TiO 2 NPs-induced activation of the AKT/mTORC2 axis. (c) Quantification of <t>RhoA</t> expression, showing TiO 2 NPs-mediated suppression of RhoA-associated cytoskeletal regulation. (d) Representative confocal fluorescence images of F-actin stained with phalloidin (green) and DAPI (blue), visualizing the disruption of cytoskeletal architecture following TiO 2 NPs exposure. (e) Quantitative analysis of relative F-actin fluorescence intensity. (f, g) Western blot (f) and densitometric analysis of the p -AKT/AKT ratio (g), demonstrating the inhibitory effect of Torin-1 on TiO 2 NPs-induced AKT hyper-phosphorylation. (h) Quantification of F-actin fluorescence intensity, showing the restoration of cytoskeletal integrity by Torin-1 intervention. (i) Quantification of RhoA levels, indicating the rescue of TiO 2 NPs-suppressed RhoA by Torin-1. (j, k) CCK-8 cell viability (j) and LDH release (k) assays assessing the impact of Torin-1 on mitigating TiO 2 NPs-induced cytotoxicity and plasma membrane rupture. (l) Representative phalloidin-stained confocal images displaying the recovery of cytoskeletal morphology in the TiO 2 NPs + Torin-1 group. (m) Intracellular GSH content, revealing that Torin-1 intervention partially mitigates TiO 2 NPs-induced depletion of antioxidant reserves. Experimental groups: Control, Torin-1, TiO 2 NPs, and TiO 2 NPs + Torin-1. Data are presented as Mean ± SEM (n ≥ 3). Statistical significance is denoted by brackets and asterisks: * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
    Rhoa G Lisa Activation Assay Kit, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 97/100, based on 697 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhoa+activation+assay+kit/RhoA+G-LISA+GTPase+Activation+Assay+Kit/pmc13597285-147-7-12
    Average 97 stars, based on 697 article reviews
    rhoa g lisa activation assay kit - by Bioz Stars, 2026-10
    97/100 stars

    Images

    1) Product Images from "Digestive-transformed titanium dioxide nanoparticles disrupt intestinal barrier via mitoxyperilysis mediated by mTOR-cytoskeleton axis dysregulation"

    Article Title: Digestive-transformed titanium dioxide nanoparticles disrupt intestinal barrier via mitoxyperilysis mediated by mTOR-cytoskeleton axis dysregulation

    Journal: Materials Today Bio

    doi: 10.1016/j.mtbio.2026.103674

    Aberrant AKT/mTORC2 signaling axis activation mediates TiO 2 NPs-induced F-actin disassembly and plasma membrane injury. (a, b) Western blot (a) and densitometric quantification of the p -AKT/AKT ratio (b), confirming TiO 2 NPs-induced activation of the AKT/mTORC2 axis. (c) Quantification of RhoA expression, showing TiO 2 NPs-mediated suppression of RhoA-associated cytoskeletal regulation. (d) Representative confocal fluorescence images of F-actin stained with phalloidin (green) and DAPI (blue), visualizing the disruption of cytoskeletal architecture following TiO 2 NPs exposure. (e) Quantitative analysis of relative F-actin fluorescence intensity. (f, g) Western blot (f) and densitometric analysis of the p -AKT/AKT ratio (g), demonstrating the inhibitory effect of Torin-1 on TiO 2 NPs-induced AKT hyper-phosphorylation. (h) Quantification of F-actin fluorescence intensity, showing the restoration of cytoskeletal integrity by Torin-1 intervention. (i) Quantification of RhoA levels, indicating the rescue of TiO 2 NPs-suppressed RhoA by Torin-1. (j, k) CCK-8 cell viability (j) and LDH release (k) assays assessing the impact of Torin-1 on mitigating TiO 2 NPs-induced cytotoxicity and plasma membrane rupture. (l) Representative phalloidin-stained confocal images displaying the recovery of cytoskeletal morphology in the TiO 2 NPs + Torin-1 group. (m) Intracellular GSH content, revealing that Torin-1 intervention partially mitigates TiO 2 NPs-induced depletion of antioxidant reserves. Experimental groups: Control, Torin-1, TiO 2 NPs, and TiO 2 NPs + Torin-1. Data are presented as Mean ± SEM (n ≥ 3). Statistical significance is denoted by brackets and asterisks: * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
    Figure Legend Snippet: Aberrant AKT/mTORC2 signaling axis activation mediates TiO 2 NPs-induced F-actin disassembly and plasma membrane injury. (a, b) Western blot (a) and densitometric quantification of the p -AKT/AKT ratio (b), confirming TiO 2 NPs-induced activation of the AKT/mTORC2 axis. (c) Quantification of RhoA expression, showing TiO 2 NPs-mediated suppression of RhoA-associated cytoskeletal regulation. (d) Representative confocal fluorescence images of F-actin stained with phalloidin (green) and DAPI (blue), visualizing the disruption of cytoskeletal architecture following TiO 2 NPs exposure. (e) Quantitative analysis of relative F-actin fluorescence intensity. (f, g) Western blot (f) and densitometric analysis of the p -AKT/AKT ratio (g), demonstrating the inhibitory effect of Torin-1 on TiO 2 NPs-induced AKT hyper-phosphorylation. (h) Quantification of F-actin fluorescence intensity, showing the restoration of cytoskeletal integrity by Torin-1 intervention. (i) Quantification of RhoA levels, indicating the rescue of TiO 2 NPs-suppressed RhoA by Torin-1. (j, k) CCK-8 cell viability (j) and LDH release (k) assays assessing the impact of Torin-1 on mitigating TiO 2 NPs-induced cytotoxicity and plasma membrane rupture. (l) Representative phalloidin-stained confocal images displaying the recovery of cytoskeletal morphology in the TiO 2 NPs + Torin-1 group. (m) Intracellular GSH content, revealing that Torin-1 intervention partially mitigates TiO 2 NPs-induced depletion of antioxidant reserves. Experimental groups: Control, Torin-1, TiO 2 NPs, and TiO 2 NPs + Torin-1. Data are presented as Mean ± SEM (n ≥ 3). Statistical significance is denoted by brackets and asterisks: * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

    Techniques Used: Activation Assay, Clinical Proteomics, Membrane, Western Blot, Expressing, Cytoskeletal, Confocal, Fluorescence, Staining, Disruption, Analysis, Phospho-proteomics, CCK-8 Assay, Morphology, Control

    Related Articles

    Activity Assay:

    Article Title: Methods and compositions for immunomodulation
    Article Snippet: .. RhoA activity: RhoA activity assays were measured by using the RhoA activation assay kit based on rhotekin pull-down, according to the manufacturer's instructions (Cytoskeleton, Denver, CO). .. RNA interference: Transfection of siRNA (20 nM) was performed with siLentFect Lipid Reagent (Bio-Rad, Hercules, CA), according to the manufacturer's protocol.

    Article Title: Genetic disruption of ATAT1 causes RhoA downregulation through abnormal truncation of C/EBPβ
    Article Snippet: .. After starvation for 12 h, mock and ATAT1 KO MDA-MB-231 cell lines stimulated with 10% FBS, for 0, 5, 15, 30, and 60 min. Then, RhoA activity was evaluated using a RhoA activation assay kit (Cytoskeleton, Denver, CO, USA, #BK036) according to the manufacturer’s protocol. ..

    Activation Assay:

    Article Title: Methods and compositions for immunomodulation
    Article Snippet: .. RhoA activity: RhoA activity assays were measured by using the RhoA activation assay kit based on rhotekin pull-down, according to the manufacturer's instructions (Cytoskeleton, Denver, CO). .. RNA interference: Transfection of siRNA (20 nM) was performed with siLentFect Lipid Reagent (Bio-Rad, Hercules, CA), according to the manufacturer's protocol.

    Article Title: Pyrin inflammasome-driven erosive arthritis caused by unprenylated RHO GTPase signaling
    Article Snippet: Cytokine concentrations in culture medium were determined by mIL-1β ELISA (88-7324-76, Thermofischer), according to the protocols provided by the manufacturer. .. RAC1-GTP assays were performed with Active RAC1-GTP pull-down assay kit (16118, Thermo Fisher Scientific), and RHOA-GTP assays were performed with RHOA activation assay kit (BK036, Cytoskeleton). ..

    Article Title: Inhibition of acid-sensing receptor GPR4 attenuates neuronal ferroptosis via RhoA/YAP signaling in a rat model of subarachnoid hemorrhage
    Article Snippet: After being treated with a 5 % nonfat milk solution (Bio--Rad Laboratories, USA) for 2 h to block nonspecific protein interactions, the membranes were then incubated overnight at 4 °C with following primary antibodies: anti-GPR4 (1:1000, PA5–118810, Thermo Fisher Scientific, Carlsbad, USA); anti-RhoA (1:1000, ab187027, Abcam, MA, USA); anti-active-YAP (1:1000, ab205270, Abcam, MA, USA); anti-ACSL4 (1:1000, MA5–42523, Thermo Fisher Scientific, Carlsbad, USA); anti-4-HNE (1:50, MA5–27570, Thermo Fisher Scientific, Carlsbad, USA); anti-β-actin (1:1000, sc-47778, Santa Cruz Biotechnology, Texas, USA). .. GTP-RhoA and total-RhoA were detected using RhoA Activation Assay Kit (BK036-S, Cytoskeleton Inc, Colorado, USA). ..

    Article Title: Pyrin inflammasome-driven erosive arthritis caused by unprenylated RHO GTPase signaling.
    Article Snippet: Cytokine concentrations in culture medium © The Author(s) EMBO Molecular Medicine 11 on Septem ber 7, 2025 from IP 103.21.124.79. were determined by mIL-1β ELISA (88-7324-76, Thermofischer), according to the protocols provided by the manufacturer .. RAC1-GTP assays were performed with Active RAC1-GTP pulldown assay kit (16118, Thermo Fisher Scientific), and RHOA-GTP assays were performed with RHOA activation assay kit (BK036, Cytoskeleton). ..

    Article Title: Genetic disruption of ATAT1 causes RhoA downregulation through abnormal truncation of C/EBPβ
    Article Snippet: .. After starvation for 12 h, mock and ATAT1 KO MDA-MB-231 cell lines stimulated with 10% FBS, for 0, 5, 15, 30, and 60 min. Then, RhoA activity was evaluated using a RhoA activation assay kit (Cytoskeleton, Denver, CO, USA, #BK036) according to the manufacturer’s protocol. ..

    Article Title: FGF12 induces aberrant mechanosignaling in aortic smooth muscle cells during thoracic aortic aneurysm formation in Marfan syndrome mice
    Article Snippet: .. Active RhoA (GTP-bound RhoA) was measured using a RhoA activation assay kit (Cytoskeleton). ..

    Article Title: Pharmacological inhibition of the RhoA pathway by melatonin reduces viral replication and proinflammatory response against ZIKV and DENV-4 neuroinfections
    Article Snippet: .. RhoA pathway activation was assessed using the RhoA Activation Assay Kit (Cytoskeleton, Denver, CO) according to the manufacturer’s instructions. ..

    Article Title: FGF12 induces aberrant mechanosignaling in aortic smooth muscle cells during thoracic aortic aneurysm formation in Marfan syndrome mice.
    Article Snippet: .. Active RhoA pulldown assay Active RhoA (GTP-bound RhoA) was measured using a RhoA activation assay kit (Cytoskeleton). ..

    Pull Down Assay:

    Article Title: Pyrin inflammasome-driven erosive arthritis caused by unprenylated RHO GTPase signaling
    Article Snippet: Cytokine concentrations in culture medium were determined by mIL-1β ELISA (88-7324-76, Thermofischer), according to the protocols provided by the manufacturer. .. RAC1-GTP assays were performed with Active RAC1-GTP pull-down assay kit (16118, Thermo Fisher Scientific), and RHOA-GTP assays were performed with RHOA activation assay kit (BK036, Cytoskeleton). ..

    Multiple Displacement Amplification:

    Article Title: Genetic disruption of ATAT1 causes RhoA downregulation through abnormal truncation of C/EBPβ
    Article Snippet: .. After starvation for 12 h, mock and ATAT1 KO MDA-MB-231 cell lines stimulated with 10% FBS, for 0, 5, 15, 30, and 60 min. Then, RhoA activity was evaluated using a RhoA activation assay kit (Cytoskeleton, Denver, CO, USA, #BK036) according to the manufacturer’s protocol. ..



    Similar Products

    97
    Cytoskeleton Inc rhoa g lisa activation assay kit
    Aberrant AKT/mTORC2 signaling axis activation mediates TiO 2 NPs-induced F-actin disassembly and plasma membrane injury. (a, b) Western blot (a) and densitometric quantification of the p -AKT/AKT ratio (b), confirming TiO 2 NPs-induced activation of the AKT/mTORC2 axis. (c) Quantification of <t>RhoA</t> expression, showing TiO 2 NPs-mediated suppression of RhoA-associated cytoskeletal regulation. (d) Representative confocal fluorescence images of F-actin stained with phalloidin (green) and DAPI (blue), visualizing the disruption of cytoskeletal architecture following TiO 2 NPs exposure. (e) Quantitative analysis of relative F-actin fluorescence intensity. (f, g) Western blot (f) and densitometric analysis of the p -AKT/AKT ratio (g), demonstrating the inhibitory effect of Torin-1 on TiO 2 NPs-induced AKT hyper-phosphorylation. (h) Quantification of F-actin fluorescence intensity, showing the restoration of cytoskeletal integrity by Torin-1 intervention. (i) Quantification of RhoA levels, indicating the rescue of TiO 2 NPs-suppressed RhoA by Torin-1. (j, k) CCK-8 cell viability (j) and LDH release (k) assays assessing the impact of Torin-1 on mitigating TiO 2 NPs-induced cytotoxicity and plasma membrane rupture. (l) Representative phalloidin-stained confocal images displaying the recovery of cytoskeletal morphology in the TiO 2 NPs + Torin-1 group. (m) Intracellular GSH content, revealing that Torin-1 intervention partially mitigates TiO 2 NPs-induced depletion of antioxidant reserves. Experimental groups: Control, Torin-1, TiO 2 NPs, and TiO 2 NPs + Torin-1. Data are presented as Mean ± SEM (n ≥ 3). Statistical significance is denoted by brackets and asterisks: * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
    Rhoa G Lisa Activation Assay Kit, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhoa+activation+assay+kit/RhoA+G-LISA+GTPase+Activation+Assay+Kit/pmc13597285-147-7-12
    Average 97 stars, based on 1 article reviews
    rhoa g lisa activation assay kit - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    96
    Cytoskeleton Inc bk036
    Aberrant AKT/mTORC2 signaling axis activation mediates TiO 2 NPs-induced F-actin disassembly and plasma membrane injury. (a, b) Western blot (a) and densitometric quantification of the p -AKT/AKT ratio (b), confirming TiO 2 NPs-induced activation of the AKT/mTORC2 axis. (c) Quantification of <t>RhoA</t> expression, showing TiO 2 NPs-mediated suppression of RhoA-associated cytoskeletal regulation. (d) Representative confocal fluorescence images of F-actin stained with phalloidin (green) and DAPI (blue), visualizing the disruption of cytoskeletal architecture following TiO 2 NPs exposure. (e) Quantitative analysis of relative F-actin fluorescence intensity. (f, g) Western blot (f) and densitometric analysis of the p -AKT/AKT ratio (g), demonstrating the inhibitory effect of Torin-1 on TiO 2 NPs-induced AKT hyper-phosphorylation. (h) Quantification of F-actin fluorescence intensity, showing the restoration of cytoskeletal integrity by Torin-1 intervention. (i) Quantification of RhoA levels, indicating the rescue of TiO 2 NPs-suppressed RhoA by Torin-1. (j, k) CCK-8 cell viability (j) and LDH release (k) assays assessing the impact of Torin-1 on mitigating TiO 2 NPs-induced cytotoxicity and plasma membrane rupture. (l) Representative phalloidin-stained confocal images displaying the recovery of cytoskeletal morphology in the TiO 2 NPs + Torin-1 group. (m) Intracellular GSH content, revealing that Torin-1 intervention partially mitigates TiO 2 NPs-induced depletion of antioxidant reserves. Experimental groups: Control, Torin-1, TiO 2 NPs, and TiO 2 NPs + Torin-1. Data are presented as Mean ± SEM (n ≥ 3). Statistical significance is denoted by brackets and asterisks: * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
    Bk036, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhoa+activation+assay+kit/RhoA+Pull-down+Activation+Assay+Biochem+Kit/pm42765771-236-44-43
    Average 96 stars, based on 1 article reviews
    bk036 - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    97
    Cytoskeleton Inc rhoa g lisa gtpase activation assay kit cytoskeleton
    Aberrant AKT/mTORC2 signaling axis activation mediates TiO 2 NPs-induced F-actin disassembly and plasma membrane injury. (a, b) Western blot (a) and densitometric quantification of the p -AKT/AKT ratio (b), confirming TiO 2 NPs-induced activation of the AKT/mTORC2 axis. (c) Quantification of <t>RhoA</t> expression, showing TiO 2 NPs-mediated suppression of RhoA-associated cytoskeletal regulation. (d) Representative confocal fluorescence images of F-actin stained with phalloidin (green) and DAPI (blue), visualizing the disruption of cytoskeletal architecture following TiO 2 NPs exposure. (e) Quantitative analysis of relative F-actin fluorescence intensity. (f, g) Western blot (f) and densitometric analysis of the p -AKT/AKT ratio (g), demonstrating the inhibitory effect of Torin-1 on TiO 2 NPs-induced AKT hyper-phosphorylation. (h) Quantification of F-actin fluorescence intensity, showing the restoration of cytoskeletal integrity by Torin-1 intervention. (i) Quantification of RhoA levels, indicating the rescue of TiO 2 NPs-suppressed RhoA by Torin-1. (j, k) CCK-8 cell viability (j) and LDH release (k) assays assessing the impact of Torin-1 on mitigating TiO 2 NPs-induced cytotoxicity and plasma membrane rupture. (l) Representative phalloidin-stained confocal images displaying the recovery of cytoskeletal morphology in the TiO 2 NPs + Torin-1 group. (m) Intracellular GSH content, revealing that Torin-1 intervention partially mitigates TiO 2 NPs-induced depletion of antioxidant reserves. Experimental groups: Control, Torin-1, TiO 2 NPs, and TiO 2 NPs + Torin-1. Data are presented as Mean ± SEM (n ≥ 3). Statistical significance is denoted by brackets and asterisks: * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
    Rhoa G Lisa Gtpase Activation Assay Kit Cytoskeleton, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhoa+activation+assay+kit/RhoA+G-LISA+GTPase+Activation+Assay+Kit/pm42732002-252-92-98
    Average 97 stars, based on 1 article reviews
    rhoa g lisa gtpase activation assay kit cytoskeleton - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    97
    Cytoskeleton Inc g lisa rhoa activation assay biochem kit
    Integrin β3 sialylation participates in HCMV-induced cytoskeleton rearrangement during viral entry. (A) Integrin β3 sialylation defect resulted in downregulation of the Integrin β3-src signaling pathway. (B) The sialylation defect also resulted in impaired HCMV-induced <t>RhoA</t> inactivation, as shown by quantification. Data are presented as mean ± standard deviation ( n = 3), with **adjusted p < 0.01 vs The ST6Gal1 shRNA group, ***adjusted p < 0.001 vs The ST6Gal1 shRNA group. (C) Integrin β3 S85 sialylation was found to facilitate stress fiber disassembly and promote viral nuclear translocation. Representative immunofluorescence images for each group are shown (magnification: 600×, scale bar: 25 μm).
    G Lisa Rhoa Activation Assay Biochem Kit, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhoa+activation+assay+kit/RhoA+G-LISA+GTPase+Activation+Assay+Kit/pmc13577289-96-7-13
    Average 97 stars, based on 1 article reviews
    g lisa rhoa activation assay biochem kit - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    97
    Cytoskeleton Inc g lisa assay kits for rhoa
    ( A ) Multiple turnover GAP activity assays with 500 nM SYDE1 and 5 μM <t>RhoA,</t> Rac1, or Cdc42. WT, wildtype; RA, R369A GAP-inactive mutant; SE, S578E phosphomimetic mutant. Data shown as mean ± SD from independent replicates (n ≥ 3). P values were calculated using ordinary one-way ANOVA with Tukey’s multiple comparisons test. ( B ) Multiple turnover GAP activity assays with 25 nM SYDE2 and 5 μM of RhoA, Rac1, or Cdc42. WT, wildtype; RA, R707A GAP-inactive mutant. Data shown as mean ± SD from independent replicates (n = 3). P values were calculated as for panel (A). ( C ) Multiple turnover GAP activity assays with 25 nM unphosphorylated (isolated from cells treated with JNK-IN-8 alone) or phosphorylated (isolated from cell treated with anisomycin) SYDE2 and 5 μM of RhoA, Rac1, or Cdc42. SYDE2 variants and significance calculations are as in panel (B). Bottom panel shows Phos-tag SDS-PAGE analysis to confirm phosphorylation states of SYDE2 used in the assays.
    G Lisa Assay Kits For Rhoa, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhoa+activation+assay+kit/RhoA+G-LISA+GTPase+Activation+Assay+Kit/bio_rxiv__64898__2026__08__31__748432-231-9-14
    Average 97 stars, based on 1 article reviews
    g lisa assay kits for rhoa - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    97
    Cytoskeleton Inc g lisa rhoa activation assay
    ( A ) Multiple turnover GAP activity assays with 500 nM SYDE1 and 5 μM <t>RhoA,</t> Rac1, or Cdc42. WT, wildtype; RA, R369A GAP-inactive mutant; SE, S578E phosphomimetic mutant. Data shown as mean ± SD from independent replicates (n ≥ 3). P values were calculated using ordinary one-way ANOVA with Tukey’s multiple comparisons test. ( B ) Multiple turnover GAP activity assays with 25 nM SYDE2 and 5 μM of RhoA, Rac1, or Cdc42. WT, wildtype; RA, R707A GAP-inactive mutant. Data shown as mean ± SD from independent replicates (n = 3). P values were calculated as for panel (A). ( C ) Multiple turnover GAP activity assays with 25 nM unphosphorylated (isolated from cells treated with JNK-IN-8 alone) or phosphorylated (isolated from cell treated with anisomycin) SYDE2 and 5 μM of RhoA, Rac1, or Cdc42. SYDE2 variants and significance calculations are as in panel (B). Bottom panel shows Phos-tag SDS-PAGE analysis to confirm phosphorylation states of SYDE2 used in the assays.
    G Lisa Rhoa Activation Assay, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhoa+activation+assay+kit/RhoA+G-LISA+GTPase+Activation+Assay+Kit/pm42687834-120-6-10
    Average 97 stars, based on 1 article reviews
    g lisa rhoa activation assay - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    97
    Cytoskeleton Inc rhoa glisa activation assay
    Effect of OBNC microspheres on regulating MSCs. A) The expression of FAK and p-FAK detected by Western blot analysis. B) Quantitative analysis of the Western blot results. C) The expression of the integrin-α5 gene. D) The expression of the integrin-α8 gene. E) The expression of the Lamb-2 gene. F) The expression of the Spp-1 gene. G) The expression of the Vav-3 gene. H) The expression of the CDC-42 gene. I) Detection of the CDC-42 active protein by a <t>GLISA</t> kit. J) Detection of Rac-1 active protein by a GLISA kit. K) Detection of Rho A active protein by a GLISA kit. L) Mechanism of OBNC hydrogels triggering the membrane receptor switch and activating integrin receptors. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001).
    Rhoa Glisa Activation Assay, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhoa+activation+assay+kit/RhoA+G-LISA+GTPase+Activation+Assay+Kit/pmc13123509-614-0-6
    Average 97 stars, based on 1 article reviews
    rhoa glisa activation assay - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    97
    Cytoskeleton Inc rhoa bk124
    Effect of OBNC microspheres on regulating MSCs. A) The expression of FAK and p-FAK detected by Western blot analysis. B) Quantitative analysis of the Western blot results. C) The expression of the integrin-α5 gene. D) The expression of the integrin-α8 gene. E) The expression of the Lamb-2 gene. F) The expression of the Spp-1 gene. G) The expression of the Vav-3 gene. H) The expression of the CDC-42 gene. I) Detection of the CDC-42 active protein by a <t>GLISA</t> kit. J) Detection of Rac-1 active protein by a GLISA kit. K) Detection of Rho A active protein by a GLISA kit. L) Mechanism of OBNC hydrogels triggering the membrane receptor switch and activating integrin receptors. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001).
    Rhoa Bk124, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhoa+activation+assay+kit/RhoA+G-LISA+GTPase+Activation+Assay+Kit/pm42587775-85-9-15
    Average 97 stars, based on 1 article reviews
    rhoa bk124 - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    96
    Cytoskeleton Inc rhoa activation assays
    Effect of OBNC microspheres on regulating MSCs. A) The expression of FAK and p-FAK detected by Western blot analysis. B) Quantitative analysis of the Western blot results. C) The expression of the integrin-α5 gene. D) The expression of the integrin-α8 gene. E) The expression of the Lamb-2 gene. F) The expression of the Spp-1 gene. G) The expression of the Vav-3 gene. H) The expression of the CDC-42 gene. I) Detection of the CDC-42 active protein by a <t>GLISA</t> kit. J) Detection of Rac-1 active protein by a GLISA kit. K) Detection of Rho A active protein by a GLISA kit. L) Mechanism of OBNC hydrogels triggering the membrane receptor switch and activating integrin receptors. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001).
    Rhoa Activation Assays, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhoa+activation+assay+kit/RhoA+Pull-down+Activation+Assay+Biochem+Kit/pmc13602547-74-0-11
    Average 96 stars, based on 1 article reviews
    rhoa activation assays - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    Image Search Results


    Aberrant AKT/mTORC2 signaling axis activation mediates TiO 2 NPs-induced F-actin disassembly and plasma membrane injury. (a, b) Western blot (a) and densitometric quantification of the p -AKT/AKT ratio (b), confirming TiO 2 NPs-induced activation of the AKT/mTORC2 axis. (c) Quantification of RhoA expression, showing TiO 2 NPs-mediated suppression of RhoA-associated cytoskeletal regulation. (d) Representative confocal fluorescence images of F-actin stained with phalloidin (green) and DAPI (blue), visualizing the disruption of cytoskeletal architecture following TiO 2 NPs exposure. (e) Quantitative analysis of relative F-actin fluorescence intensity. (f, g) Western blot (f) and densitometric analysis of the p -AKT/AKT ratio (g), demonstrating the inhibitory effect of Torin-1 on TiO 2 NPs-induced AKT hyper-phosphorylation. (h) Quantification of F-actin fluorescence intensity, showing the restoration of cytoskeletal integrity by Torin-1 intervention. (i) Quantification of RhoA levels, indicating the rescue of TiO 2 NPs-suppressed RhoA by Torin-1. (j, k) CCK-8 cell viability (j) and LDH release (k) assays assessing the impact of Torin-1 on mitigating TiO 2 NPs-induced cytotoxicity and plasma membrane rupture. (l) Representative phalloidin-stained confocal images displaying the recovery of cytoskeletal morphology in the TiO 2 NPs + Torin-1 group. (m) Intracellular GSH content, revealing that Torin-1 intervention partially mitigates TiO 2 NPs-induced depletion of antioxidant reserves. Experimental groups: Control, Torin-1, TiO 2 NPs, and TiO 2 NPs + Torin-1. Data are presented as Mean ± SEM (n ≥ 3). Statistical significance is denoted by brackets and asterisks: * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

    Journal: Materials Today Bio

    Article Title: Digestive-transformed titanium dioxide nanoparticles disrupt intestinal barrier via mitoxyperilysis mediated by mTOR-cytoskeleton axis dysregulation

    doi: 10.1016/j.mtbio.2026.103674

    Figure Lengend Snippet: Aberrant AKT/mTORC2 signaling axis activation mediates TiO 2 NPs-induced F-actin disassembly and plasma membrane injury. (a, b) Western blot (a) and densitometric quantification of the p -AKT/AKT ratio (b), confirming TiO 2 NPs-induced activation of the AKT/mTORC2 axis. (c) Quantification of RhoA expression, showing TiO 2 NPs-mediated suppression of RhoA-associated cytoskeletal regulation. (d) Representative confocal fluorescence images of F-actin stained with phalloidin (green) and DAPI (blue), visualizing the disruption of cytoskeletal architecture following TiO 2 NPs exposure. (e) Quantitative analysis of relative F-actin fluorescence intensity. (f, g) Western blot (f) and densitometric analysis of the p -AKT/AKT ratio (g), demonstrating the inhibitory effect of Torin-1 on TiO 2 NPs-induced AKT hyper-phosphorylation. (h) Quantification of F-actin fluorescence intensity, showing the restoration of cytoskeletal integrity by Torin-1 intervention. (i) Quantification of RhoA levels, indicating the rescue of TiO 2 NPs-suppressed RhoA by Torin-1. (j, k) CCK-8 cell viability (j) and LDH release (k) assays assessing the impact of Torin-1 on mitigating TiO 2 NPs-induced cytotoxicity and plasma membrane rupture. (l) Representative phalloidin-stained confocal images displaying the recovery of cytoskeletal morphology in the TiO 2 NPs + Torin-1 group. (m) Intracellular GSH content, revealing that Torin-1 intervention partially mitigates TiO 2 NPs-induced depletion of antioxidant reserves. Experimental groups: Control, Torin-1, TiO 2 NPs, and TiO 2 NPs + Torin-1. Data are presented as Mean ± SEM (n ≥ 3). Statistical significance is denoted by brackets and asterisks: * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

    Article Snippet: Intracellular RhoA activity was quantified utilizing the RhoA G-LISA Activation Assay Kit (Cytoskeleton; supplied by Jianglai Biotechnology, Shanghai, China; cat. no. CSK-BK124-S).

    Techniques: Activation Assay, Clinical Proteomics, Membrane, Western Blot, Expressing, Cytoskeletal, Confocal, Fluorescence, Staining, Disruption, Analysis, Phospho-proteomics, CCK-8 Assay, Morphology, Control

    Integrin β3 sialylation participates in HCMV-induced cytoskeleton rearrangement during viral entry. (A) Integrin β3 sialylation defect resulted in downregulation of the Integrin β3-src signaling pathway. (B) The sialylation defect also resulted in impaired HCMV-induced RhoA inactivation, as shown by quantification. Data are presented as mean ± standard deviation ( n = 3), with **adjusted p < 0.01 vs The ST6Gal1 shRNA group, ***adjusted p < 0.001 vs The ST6Gal1 shRNA group. (C) Integrin β3 S85 sialylation was found to facilitate stress fiber disassembly and promote viral nuclear translocation. Representative immunofluorescence images for each group are shown (magnification: 600×, scale bar: 25 μm).

    Journal: Virulence

    Article Title: Integrin β3 α2,6-sialylation by the sialyltransferase ST6Gal1 promotes human cytomegalovirus entry into fibroblasts

    doi: 10.1080/21505594.2026.2732519

    Figure Lengend Snippet: Integrin β3 sialylation participates in HCMV-induced cytoskeleton rearrangement during viral entry. (A) Integrin β3 sialylation defect resulted in downregulation of the Integrin β3-src signaling pathway. (B) The sialylation defect also resulted in impaired HCMV-induced RhoA inactivation, as shown by quantification. Data are presented as mean ± standard deviation ( n = 3), with **adjusted p < 0.01 vs The ST6Gal1 shRNA group, ***adjusted p < 0.001 vs The ST6Gal1 shRNA group. (C) Integrin β3 S85 sialylation was found to facilitate stress fiber disassembly and promote viral nuclear translocation. Representative immunofluorescence images for each group are shown (magnification: 600×, scale bar: 25 μm).

    Article Snippet: Intracellular GTP-RhoA activity was determined using the G-LISA RhoA Activation Assay Biochem Kit (Cytoskeleton Inc., Cat#BK124, Denver, USA) according to the manufacturer’s instructions.

    Techniques: Standard Deviation, shRNA, Translocation Assay, Immunofluorescence

    ( A ) Multiple turnover GAP activity assays with 500 nM SYDE1 and 5 μM RhoA, Rac1, or Cdc42. WT, wildtype; RA, R369A GAP-inactive mutant; SE, S578E phosphomimetic mutant. Data shown as mean ± SD from independent replicates (n ≥ 3). P values were calculated using ordinary one-way ANOVA with Tukey’s multiple comparisons test. ( B ) Multiple turnover GAP activity assays with 25 nM SYDE2 and 5 μM of RhoA, Rac1, or Cdc42. WT, wildtype; RA, R707A GAP-inactive mutant. Data shown as mean ± SD from independent replicates (n = 3). P values were calculated as for panel (A). ( C ) Multiple turnover GAP activity assays with 25 nM unphosphorylated (isolated from cells treated with JNK-IN-8 alone) or phosphorylated (isolated from cell treated with anisomycin) SYDE2 and 5 μM of RhoA, Rac1, or Cdc42. SYDE2 variants and significance calculations are as in panel (B). Bottom panel shows Phos-tag SDS-PAGE analysis to confirm phosphorylation states of SYDE2 used in the assays.

    Journal: bioRxiv

    Article Title: Functional characterization of Rho GTPase activating proteins SYDE1 and SYDE2

    doi: 10.64898/2026.08.31.748432

    Figure Lengend Snippet: ( A ) Multiple turnover GAP activity assays with 500 nM SYDE1 and 5 μM RhoA, Rac1, or Cdc42. WT, wildtype; RA, R369A GAP-inactive mutant; SE, S578E phosphomimetic mutant. Data shown as mean ± SD from independent replicates (n ≥ 3). P values were calculated using ordinary one-way ANOVA with Tukey’s multiple comparisons test. ( B ) Multiple turnover GAP activity assays with 25 nM SYDE2 and 5 μM of RhoA, Rac1, or Cdc42. WT, wildtype; RA, R707A GAP-inactive mutant. Data shown as mean ± SD from independent replicates (n = 3). P values were calculated as for panel (A). ( C ) Multiple turnover GAP activity assays with 25 nM unphosphorylated (isolated from cells treated with JNK-IN-8 alone) or phosphorylated (isolated from cell treated with anisomycin) SYDE2 and 5 μM of RhoA, Rac1, or Cdc42. SYDE2 variants and significance calculations are as in panel (B). Bottom panel shows Phos-tag SDS-PAGE analysis to confirm phosphorylation states of SYDE2 used in the assays.

    Article Snippet: GTP-bound GTPase levels in cell lysates were measured using G-LISA assay kits for RhoA (Cytoskeleton, Inc. #BK124), Rac1 (Cytoskeleton, Inc. #BK128), and Cdc42 (Cytoskeleton, Inc. #BK127).

    Techniques: Activity Assay, Mutagenesis, Isolation, SDS Page, Phospho-proteomics

    ( A ) G-LISA effector binding assays for RhoA, Rac1, and Cdc42 in lysates from SYDE1 KO Swan 71 cells expressing the following constructs: GFP (−), SYDE1-GFP WT (WT), SYDE1-GFP R369A (RA), SYDE1-GFP S578E (SE). Data shown as mean ± SD from independent replicates (n = 5). All pairwise comparisons were insignificant (P >0.05) by ordinary one-way ANOVA with Tukey’s multiple comparisons test. ( B ) G-LISA effector interaction assays for RhoA, Rac1, and Cdc42 in lysates from HEK293 cells expressing GFP, SYDE1-GFP WT, RA, SE, and S578A (SA). Data shown as mean ± SD from independent replicates (n = 3). All pairwise comparisons were insignificant (P >0.05) by ordinary one-way ANOVA with Tukey’s multiple comparisons test. ( C ) G-LISA assays for RhoA, Rac1, and Cdc42 in lysates from HEK293 cells expressing GFP, SYDE2-GFP WT (WT), R707A (RA), S935D (SD), and S935A (SA). Data shown as mean ± SD from independent replicates (n = 3). All pairwise comparisons were insignificant (P >0.05) by ordinary one-way ANOVA with Tukey’s multiple comparisons test.

    Journal: bioRxiv

    Article Title: Functional characterization of Rho GTPase activating proteins SYDE1 and SYDE2

    doi: 10.64898/2026.08.31.748432

    Figure Lengend Snippet: ( A ) G-LISA effector binding assays for RhoA, Rac1, and Cdc42 in lysates from SYDE1 KO Swan 71 cells expressing the following constructs: GFP (−), SYDE1-GFP WT (WT), SYDE1-GFP R369A (RA), SYDE1-GFP S578E (SE). Data shown as mean ± SD from independent replicates (n = 5). All pairwise comparisons were insignificant (P >0.05) by ordinary one-way ANOVA with Tukey’s multiple comparisons test. ( B ) G-LISA effector interaction assays for RhoA, Rac1, and Cdc42 in lysates from HEK293 cells expressing GFP, SYDE1-GFP WT, RA, SE, and S578A (SA). Data shown as mean ± SD from independent replicates (n = 3). All pairwise comparisons were insignificant (P >0.05) by ordinary one-way ANOVA with Tukey’s multiple comparisons test. ( C ) G-LISA assays for RhoA, Rac1, and Cdc42 in lysates from HEK293 cells expressing GFP, SYDE2-GFP WT (WT), R707A (RA), S935D (SD), and S935A (SA). Data shown as mean ± SD from independent replicates (n = 3). All pairwise comparisons were insignificant (P >0.05) by ordinary one-way ANOVA with Tukey’s multiple comparisons test.

    Article Snippet: GTP-bound GTPase levels in cell lysates were measured using G-LISA assay kits for RhoA (Cytoskeleton, Inc. #BK124), Rac1 (Cytoskeleton, Inc. #BK128), and Cdc42 (Cytoskeleton, Inc. #BK127).

    Techniques: Binding Assay, Expressing, Construct

    Effect of OBNC microspheres on regulating MSCs. A) The expression of FAK and p-FAK detected by Western blot analysis. B) Quantitative analysis of the Western blot results. C) The expression of the integrin-α5 gene. D) The expression of the integrin-α8 gene. E) The expression of the Lamb-2 gene. F) The expression of the Spp-1 gene. G) The expression of the Vav-3 gene. H) The expression of the CDC-42 gene. I) Detection of the CDC-42 active protein by a GLISA kit. J) Detection of Rac-1 active protein by a GLISA kit. K) Detection of Rho A active protein by a GLISA kit. L) Mechanism of OBNC hydrogels triggering the membrane receptor switch and activating integrin receptors. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001).

    Journal: Bioactive Materials

    Article Title: Mechanically sensitized hydrogel microspheres trigger membrane receptor switch for cartilage repair

    doi: 10.1016/j.bioactmat.2026.03.017

    Figure Lengend Snippet: Effect of OBNC microspheres on regulating MSCs. A) The expression of FAK and p-FAK detected by Western blot analysis. B) Quantitative analysis of the Western blot results. C) The expression of the integrin-α5 gene. D) The expression of the integrin-α8 gene. E) The expression of the Lamb-2 gene. F) The expression of the Spp-1 gene. G) The expression of the Vav-3 gene. H) The expression of the CDC-42 gene. I) Detection of the CDC-42 active protein by a GLISA kit. J) Detection of Rac-1 active protein by a GLISA kit. K) Detection of Rho A active protein by a GLISA kit. L) Mechanism of OBNC hydrogels triggering the membrane receptor switch and activating integrin receptors. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001).

    Article Snippet: RhoA GLISA Activation Assay (No. BK124, Cytoskeleton, USA), CDC42 GLISA Activation Assay (No. BK127, Cytoskeleton, USA), and Rac1 GLISA Activation Assay (No. BK128, Cytoskeleton, USA) were used to measure the activation of the GTPase protein family.

    Techniques: Expressing, Western Blot, Membrane